Figure 1 Neutralization titers from the wild-type virus assay: In this particular cell-based assay, the maximum value obtainable in this assay was 1:2560 which is the top dilution in the series.

High-throughput clinical assay detects, quantifies SARS-CoV-2-neutralizing antibodiesImanis Life Sciences is an affiliate of Vyriad Inc.ROCHESTER, Minn., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Imanis ...

The previously observed neutralization data of these subjects were replicated using the whole-blood IP-10 assay. Finally, the researchers investigated the impact of genetic deficiency on type I ...

Moreover, there is large assay variability due limited standardization of the neutralization evaluation point. The titers can vary significantly based on the testing conditions, viral strains ...

Researchers used AI models to design antibodies that neutralize over 1,300 SARS-CoV-2 strains, including Delta and Omicron. The models demonstrated faster, cheaper, and more adaptable therapeutic ...

High-throughput clinical assay detects and quantifies SARS-CoV-2 neutralizing antibodiesROCHESTER, Minn., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Imanis Life Sciences, LLC (“Imanis” or ...

The nAbCyte cell-based neutralizing antibody assay is a component of Pfizer's program to target recombinant adeno-associated virus (rAAV)-based gene therapies to the appropriate patient population.

The nAbCyte cell-based neutralizing antibody assay detects AAVRh74var pre-existing neutralizing antibodies, which could impact the efficacy of Beqvez. Patients should be tested for pre-existing ...

Labcorp, a global leader of innovative and comprehensive laboratory services, announced the US Food and Drug Administration (FDA) has approved its nAbCyte Anti-AAVRh74var HB-FE Assay, a companion ...